Single-Cell Transcriptomic Identification of Drug Repurposing Candidates for White Adipose Tissue Browning via scVI Embedding and LINCS L1000 Matching

Read full text Summarise with VIRAT
Authors: Glen Charles Ritschel, Claude
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Preprint companion to a provisional patent application reporting computational identification of drug repurposing candidates for white adipose tissue (WAT) browning. Single-cell RNA sequencing data from GEO dataset GSE176171 (human adipose tissue atlas, 137,684 total cells, visceral and subcutaneous depots) was processed through quality control (45,201 cells retained), scVI variational autoencoder embedding (n_latent=30), and Leiden clustering (26 clusters). Nine target clusters corresponding to fat cells (n=9,060) and macrophages (n=6,052) were identified. Wilcoxon rank-sum differential expression analysis yielded 27,333 significant DE genes. Enrichr matching against LINCS L1000 Consensus Chemical Perturbation Signatures identified 4,700 drug repurposing candidates. Top candidates include camptothecin, MG-132, GW-5074, wortmannin, and BMS-754807. Five cross-disease signals — WZ-3105 (SRC/ABL), QL-XII-47 (MELK/FLT3), R-547 (CDK), SAR405838 (MDM2), and KPT-330/selinexor (XPO1) — were identified as consistent candidates across 5–20 independent disease scRNA-seq analyses in this portfolio.

Fields of Study & Subjects

Adipose Tissue and Metabolism Single-cell and spatial transcriptomics Computational Drug Discovery Methods

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 March 2026
Language
EN
Document type
Preprint